Pronounced antiseizure activity of the subtype‐selective GABA(A) positive allosteric modulator darigabat in a mouse model of drug‐resistant focal epilepsy

por Gurrell, Rachel, Iredale, Philip, Evrard, Alexis, Duveau, Venceslas, Ruggiero, Céline, Roucard, Corinne
Publicado 2022

Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB(1)) Receptor Antagonist

por Hadcock, John R, Carpino, Philip A, Iredale, Philip A, Dow, Robert L, Gautreau, Denise, Thiede, Lucinda, Kelly-Sullivan, Dawn, Lizano, Jeffrey S, Liu, Xingrong, Van Deusen, Jeffrey, Ward, Karen M, O'Connor, Rebecca E, Black, Shawn C, Griffith, David A, Scott, Dennis O
Publicado 2010